Application of Bayesian Spatial-temporal Models for Estimating Unrecognized COVID-19 Deaths in the United States
Overview
Affiliations
In the United States, COVID-19 has become a leading cause of death since 2020. However, the number of COVID-19 deaths reported from death certificates is likely to represent an underestimate of the total deaths related to SARS-CoV-2 infections. Estimating those deaths not captured through death certificates is important to understanding the full burden of COVID-19 on mortality. In this work, we explored enhancements to an existing approach by employing Bayesian hierarchical models to estimate unrecognized deaths attributed to COVID-19 using weekly state-level COVID-19 viral surveillance and mortality data in the United States from March 2020 to April 2021. We demonstrated our model using those aged years who died. First, we used a spatial-temporal binomial regression model to estimate the percent of positive SARS-CoV-2 test results. A spatial-temporal negative-binomial model was then used to estimate unrecognized COVID-19 deaths by exploiting the spatial-temporal association between SARS-CoV-2 percent positive and all-cause mortality counts using an excess mortality approach. Computationally efficient Bayesian inference was accomplished via the Polya-Gamma representation of the binomial and negative-binomial models. Among those aged years, we estimated 58,200 (95% CI: 51,300, 64,900) unrecognized COVID-19 deaths, which accounts for 26% (95% CI: 24%, 29%) of total COVID-19 deaths in this age group. Our modeling results suggest that COVID-19 mortality and the proportion of unrecognized deaths among deaths attributed to COVID-19 vary by time and across states.
Excess natural-cause mortality in US counties and its association with reported COVID-19 deaths.
Paglino E, Lundberg D, Wrigley-Field E, Zhou Z, Wasserman J, Raquib R Proc Natl Acad Sci U S A. 2024; 121(6):e2313661121.
PMID: 38300867 PMC: 10861891. DOI: 10.1073/pnas.2313661121.
Kandula S, Keyes K, Yaari R, Shaman J medRxiv. 2024; .
PMID: 38293208 PMC: 10827264. DOI: 10.1101/2024.01.14.24301290.
Ara T, Kitamura H Medicines (Basel). 2023; 10(11).
PMID: 37999201 PMC: 10672774. DOI: 10.3390/medicines10110061.
Paglino E, Lundberg D, Zhou Z, Wasserman J, Raquib R, Luck A Sci Adv. 2023; 9(25):eadf9742.
PMID: 37352359 PMC: 10289647. DOI: 10.1126/sciadv.adf9742.
COVID-19 outbreaks analysis in the Valencian Region of Spain in the prelude of the third wave.
Fuente D, Hervas D, Rebollo M, Conejero J, Oliver N Front Public Health. 2022; 10:1010124.
PMID: 36466513 PMC: 9713945. DOI: 10.3389/fpubh.2022.1010124.